Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...
A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy.
Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.
A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...
Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.
2d
Pharmaceutical Technology on MSNWeill Cancer Hub East launches to transform treatmentThe Weill Cancer Hub East, a collaborative initiative formed by Weill Cornell Medicine, Princeton University, The Rockefeller ...
Researchers show that the immune system can recognize and control the latent stage of the parasite Toxoplasma gondii, a finding that can inform the study of latency in other infections of the nervous ...
The hub will evaluate how emerging therapeutics, including GLP-1 agonists, might impact cancer progression and treatment.
A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.
A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...
A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results